• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国类风湿关节炎发病率和死亡率的趋势及未来预测:基于 GBD 2021 数据的系统分析。

Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.

机构信息

Department of Rheumatology and Immunology, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China.

Department of Rheumatology and Immunology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, 223001, China.

出版信息

Clin Rheumatol. 2024 Sep;43(9):2799-2806. doi: 10.1007/s10067-024-07083-3. Epub 2024 Jul 29.

DOI:10.1007/s10067-024-07083-3
PMID:39073512
Abstract

This study aims to evaluate the trends in rheumatoid arthritis (RA) in China from 1990 to 2021 by analyzing data from the Global Burden of Disease (GBD) 2021 study and to predict the trends for the next 25 years. Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) were calculated, and the estimated annual percentage change was used to illustrate differences in age distribution among various populations. Age-period-cohort (APC) analysis and Bayesian APC (BAPC) models were employed to forecast the burden of RA in China from 2022 to 2046. From 1990 to 2021, the ASIR of RA in China increased from 11.6 to 13.7, with a significantly higher ASIR in females than in males. Despite the increase in incidence, the ASMR related to RA decreased from 0.7 to 0.5. Predictions using the BAPC model indicate that the incidence of RA will continue to rise, with an expected ASIR of approximately 16.4 by 2046, and the total number of RA cases is projected to reach around 342,000. In terms of mortality, the ASMR is expected to decline to 0.3 by 2046, although the total number of deaths might reach about 40,000. The incidence of RA in China has significantly increased over the past 30 years. Although the incidence rate and the total number of RA cases may continue to rise in the future, the mortality rate of RA has been consistently declining. Key Points • Over the past 30 years, the incidence of RA in China has significantly increased; although the incidence rate and total number of cases may continue to rise, the mortality rate has been consistently declining.

摘要

这项研究旨在通过分析全球疾病负担(GBD)2021 研究的数据,评估 1990 年至 2021 年中国类风湿关节炎(RA)的趋势,并预测未来 25 年的趋势。计算了年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR),并使用估计的年百分变化来说明不同人群年龄分布的差异。采用年龄-时期-队列(APC)分析和贝叶斯 APC(BAPC)模型预测中国 2022 年至 2046 年 RA 的负担。1990 年至 2021 年,中国 RA 的 ASIR 从 11.6 增加到 13.7,女性的 ASIR 明显高于男性。尽管发病率有所上升,但与 RA 相关的 ASMR 从 0.7 下降到 0.5。使用 BAPC 模型进行预测表明,RA 的发病率将继续上升,预计到 2046 年 ASIR 将达到约 16.4,RA 病例总数预计将达到约 342000 例。在死亡率方面,预计到 2046 年 ASMR 将下降到 0.3,但死亡总数可能达到约 40000 例。中国 RA 的发病率在过去 30 年中显著增加。尽管未来发病率和 RA 总病例数可能继续上升,但 RA 的死亡率一直在持续下降。关键要点: • 在过去 30 年中,中国 RA 的发病率显著增加;尽管发病率和总病例数可能继续上升,但死亡率一直在持续下降。

相似文献

1
Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.中国类风湿关节炎发病率和死亡率的趋势及未来预测:基于 GBD 2021 数据的系统分析。
Clin Rheumatol. 2024 Sep;43(9):2799-2806. doi: 10.1007/s10067-024-07083-3. Epub 2024 Jul 29.
2
Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019.估算 2019 年全球类风湿性关节炎的患病率、发病率、残疾年数和 2040 年预测发病率:来自 2019 年全球疾病负担研究的结果。
Clin Rheumatol. 2023 Sep;42(9):2297-2309. doi: 10.1007/s10067-023-06628-2. Epub 2023 Jun 9.
3
Secular trend of mortality and incidence of rheumatoid arthritis in global ,1990-2019: an age period cohort analysis and joinpoint analysis.全球范围内类风湿关节炎死亡率和发病率的长期趋势:1990-2019 年的年龄-时期-队列分析和联合分析。
BMC Pulm Med. 2023 Sep 22;23(1):356. doi: 10.1186/s12890-023-02594-2.
4
[Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].[1990年至2030年中国酒精所致肝硬化及其他慢性肝病疾病负担的分析与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):185-191. doi: 10.3760/cma.j.cn112338-20230920-00173.
5
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019.1 型和 2 型糖尿病死亡负担:基于中国和全球 1990 年至 2019 年死亡率负担的贝叶斯年龄-时期-队列分析对 2030 年的预测。
J Diabetes Investig. 2024 May;15(5):623-633. doi: 10.1111/jdi.14146. Epub 2024 Jan 24.
6
Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020-2040.中国甲状腺癌趋势及其与 G20 国家的对比分析:2020-2040 年预测。
J Glob Health. 2024 Jun 14;14:04131. doi: 10.7189/jogh.14.04131.
7
Changing Trends in the Global Disease Burden of Pancreatic Cancer from 1990 to 2030.1990年至2030年全球胰腺癌疾病负担的变化趋势
Dig Dis Sci. 2024 Jul;69(7):2450-2461. doi: 10.1007/s10620-024-08465-y. Epub 2024 May 9.
8
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.204 个国家 1990-2019 年胃癌发病、死亡、伤残调整生命年及危险因素负担:2019 年全球疾病负担研究
J Gastrointest Cancer. 2024 Jun;55(2):787-799. doi: 10.1007/s12029-023-01005-3. Epub 2024 Jan 24.
9
Global, regional, and national cancer burdens of respiratory and digestive tracts in 1990-2044: A cross-sectional and age-period-cohort forecast study.1990-2044 年全球、区域和国家的呼吸道和消化道癌症负担:一项横断面和年龄-时期-队列预测研究。
Cancer Epidemiol. 2024 Aug;91:102583. doi: 10.1016/j.canep.2024.102583. Epub 2024 May 29.
10
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): an analysis based on the global burden of disease study 2021.青少年和青年(15-39 岁)自身免疫性疾病的标准化发病率、患病率和死亡率:基于 2021 年全球疾病负担研究的分析。
BMC Public Health. 2024 Jul 5;24(1):1800. doi: 10.1186/s12889-024-19290-3.

引用本文的文献

1
Global, regional, and national burden of early-onset ischemic heart disease: trends and projections among adults aged 15-44 years from 1990 to 2046.早发性缺血性心脏病的全球、区域和国家负担:1990年至2046年15至44岁成年人的趋势和预测
Front Cardiovasc Med. 2025 Aug 29;12:1653335. doi: 10.3389/fcvm.2025.1653335. eCollection 2025.
2
Temporal Trends of Polycystic Ovary Syndrome Burden in the East and Southeast Asia from 1990 to 2021: An Analysis from the Global Burden of Disease Study 2021.1990年至2021年东亚和东南亚多囊卵巢综合征负担的时间趋势:来自《2021年全球疾病负担研究》的分析
Int J Womens Health. 2025 Jul 15;17:2097-2108. doi: 10.2147/IJWH.S523350. eCollection 2025.
3

本文引用的文献

1
Global Burden of Disease Study 2021 estimates: implications for health policy and research.《2021年全球疾病负担研究》估算:对卫生政策与研究的影响
Lancet. 2024 May 18;403(10440):1958-1959. doi: 10.1016/S0140-6736(24)00812-2. Epub 2024 Apr 17.
2
Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040.基于人群的德国类风湿关节炎流行病学预测至 2040 年。
Scand J Rheumatol. 2024 May;53(3):161-172. doi: 10.1080/03009742.2024.2312693. Epub 2024 Feb 15.
3
Rheumatoid arthritis.类风湿关节炎。
Global, Regional and National Burden of Low Back Pain in Adolescents Aged 10-19 years, 1990-2021: A Systematic Analysis of the Global Burden of Disease Study 2021.
1990年至2021年10至19岁青少年下背痛的全球、区域和国家负担:全球疾病负担研究2021的系统分析
J Pain Res. 2025 Jun 26;18:3171-3183. doi: 10.2147/JPR.S525330. eCollection 2025.
4
Epidemiological Trends and Projection of Liver Cancer Due to Nonalcoholic Steatohepatitis Among People Aged 55 Years and Older in China From 1990 to 2030: An Analysis of the Global Burden of Disease Study 2021.1990年至2030年中国55岁及以上人群非酒精性脂肪性肝炎所致肝癌的流行病学趋势及预测:全球疾病负担研究2021分析
Clin Transl Gastroenterol. 2025 Jun 11;16(8):e00872. doi: 10.14309/ctg.0000000000000872. eCollection 2025 Aug 1.
5
Global, regional, and national burdens of rheumatoid arthritis among people aged 60 years and older from 1990 to 2021: a trend analysis for the Global Burden of Disease Study 2021.1990年至2021年60岁及以上人群中类风湿关节炎的全球、区域和国家负担:全球疾病负担研究2021的趋势分析
Front Public Health. 2025 May 26;13:1527680. doi: 10.3389/fpubh.2025.1527680. eCollection 2025.
6
Global burden of pediatric fracture (1992-2021) and projections of future disease burden trends.1992 - 2021年全球儿童骨折负担及未来疾病负担趋势预测
BMC Pediatr. 2025 May 24;25(1):416. doi: 10.1186/s12887-025-05767-6.
7
Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry.类风湿关节炎靶向治疗的真实世界安全性和有效性:来自FIRST注册研究的5年5130例病例随访
Rheumatol Ther. 2025 Jun;12(3):561-580. doi: 10.1007/s40744-025-00762-w. Epub 2025 Apr 21.
8
Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop:.左心室射血分数保留的类风湿关节炎患者心肌工作与疾病活动的相关性:基于无创压力-应变环的回顾性研究
Clin Rheumatol. 2025 Apr;44(4):1513-1525. doi: 10.1007/s10067-025-07380-5. Epub 2025 Mar 5.
9
Age-period-cohort analysis and prediction of tuberculosis trends in China-based on the Global Burden of Disease 2021 data.基于《2021年全球疾病负担》数据的中国结核病趋势的年龄-时期-队列分析与预测
Front Public Health. 2025 Feb 14;13:1512514. doi: 10.3389/fpubh.2025.1512514. eCollection 2025.
10
The role of quercetin in NLRP3-associated inflammation.槲皮素在 NLRP3 相关炎症中的作用。
Inflammopharmacology. 2024 Dec;32(6):3585-3610. doi: 10.1007/s10787-024-01566-0. Epub 2024 Sep 22.
Lancet. 2023 Nov 25;402(10416):2019-2033. doi: 10.1016/S0140-6736(23)01525-8. Epub 2023 Oct 27.
4
The plight and light of treating rheumatoid arthritis in China.中国类风湿关节炎治疗的困境与希望
Lancet Rheumatol. 2019 Oct;1(2):e81-e82. doi: 10.1016/S2665-9913(19)30039-6. Epub 2019 Sep 25.
5
Association between human papillomavirus infection or immunization and risk for rheumatoid arthritis.人乳头瘤病毒感染或免疫与类风湿关节炎风险的关系。
Front Immunol. 2023 Apr 14;14:1130217. doi: 10.3389/fimmu.2023.1130217. eCollection 2023.
6
Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking.职业可吸入性物质是类风湿关节炎的主要危险因素,特别是在遗传易感性和吸烟的背景下。
Ann Rheum Dis. 2023 Mar;82(3):316-323. doi: 10.1136/ard-2022-223134. Epub 2022 Dec 6.
7
Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study.全球、区域和国家类风湿性关节炎负担,以及 1990 年至 2019 年的归因风险因素:来自 2019 年全球疾病负担研究的更新。
Clin Exp Rheumatol. 2023 Jul;41(7):1516-1527. doi: 10.55563/clinexprheumatol/h9lvvc. Epub 2022 Dec 5.
8
The Current Status and Challenges in the Diagnosis and Treatment of Rheumatoid Arthritis in China: An Annual Report of 2019.中国类风湿关节炎诊断与治疗的现状及挑战:2019年年报
Rheumatol Immunol Res. 2021 Apr 13;2(1):49-56. doi: 10.2478/rir-2021-0008. eCollection 2021 Mar.
9
2018 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis.《2018年中国类风湿关节炎诊疗指南》
Rheumatol Immunol Res. 2021 Apr 13;2(1):1-14. doi: 10.2478/rir-2021-0002. eCollection 2021 Mar.
10
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studies.脊柱关节炎和类风湿关节炎患者健康相关生活质量的决定因素——COMOSPA 和 COMORA 研究的数据。
Semin Arthritis Rheum. 2022 Dec;57:152086. doi: 10.1016/j.semarthrit.2022.152086. Epub 2022 Aug 27.